Consistently, AML-MSC-EVs regulate the AML progression promoting cell proliferation, migration, and invasion, inhibiting GSK3β expression and activating Wnt/β-catenin signaling in AML cells [48]. The gene discussed is GSK3B; the disease is acute myeloid leukemia.